Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chen CL
------>authors3_c=?
------>paper_class1=1
------>Impact_Factor=11.673
------>paper_class3=2
------>paper_class2=1
------>vol=135
------>confirm_bywho=hychiou
------>insert_bywho=liyu
------>Jurnal_Rank=2.0
------>authors4_c=?
------>comm_author=
------>patent_EDate=None
------>authors5_c=?
------>publish_day=20
------>paper_class2Letter=None
------>page2=121
------>medlineContent=
------>unit=J0200
------>insert_date=20081127
------>iam=7
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=?
------>score=500
------>journal_name=Gastroenterology
------>paper_name=Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
------>confirm_date=20081203
------>tch_id=097008
------>pmid=18505690
------>page1=111
------>fullAbstract=BACKGROUND & AIMS: This study investigated whether obesity, diabetes, and other metabolic factors are independently associated with hepatocellular carcinoma (HCC), stratified by hepatitis B virus (HBV) and hepatitis C virus (HCV) serostatus, and explored the possible joint influence of obesity/diabetes and HBV/HCV infections on the risk of HCC. METHODS: A total of 23,820 residents in Taiwan were recruited and followed up for 14 years. All analyses were stratified by hepatitis B surface antigen (HBsAg) and antibody to HCV (anti-HCV) at enrollment, and 218 subjects positive for both seromarkers were excluded. Incident HCC cases were identified via linkage to the national cancer registry. Multivariate-adjusted relative risk (RR(a)) and 95% confidence interval (95% CI) were estimated using Cox proportional hazards models. RESULTS: Extreme obesity (body mass index >or=30 kg/m(2)) was independently associated with a 4-fold risk of HCC (RR(a), 4.13; 95% CI, 1.38-12.4) among anti-HCV-seropositive subjects and a 2-fold risk (RR(a), 2.36; 95% CI, 0.91-6.17) in persons without HBV and HCV infections, after controlling for other metabolic components, but not in HBsAg-seropositive subjects (RR(a), 1.36; 95% CI, 0.64-2.89). Diabetes was associated with HCC in all 3 groups, with the highest risk in those with HCV infection (RR(a), 3.52; 95% CI, 1.29-9.24) and lowest in HBV carriers (RR(a), 2.27; 95% CI, 1.10-4.66). We found more than 100-fold increased risk in HBV or HCV carriers with both obesity and diabetes, indicating synergistic effects of metabolic factors and hepatitis. CONCLUSIONS: The finding that both obesity and diabetes are predictors of HCC risk, possibly differently depending on HBV and HCV infection status, may shed some light in preventing HCC.
------>tmu_sno=None
------>sno=19915
------>authors2=Yang HI
------>authors3=Yang WS
------>authors4=Liu CJ
------>authors5=Chen PJ
------>authors6=You SL, Wang LY
------>authors6_c=?, ???
------>authors=Chen CL
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=?
------>publish_area=0
------>updateTitle=Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2008
------>submit_flag=None
------>publish_month=8
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z